Biodesix Inc - SIC # 8071 - MEDICAL LABORATORIES

Ticker Exchange SIC # Website Latest Ticker
BDSX Nasdaq 8071 https://www.biodesix.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Biodesix Inc

Bullish Biodesix, Inc. (NASDAQ:BDSX) insiders filled their treasuries with US$34m worth of stock over last year - Mar 15th, 2023 1:31 pm
Biodesix, Inc. (NASDAQ:BDSX) Q4 2022 Earnings Call Transcript - Mar 8th, 2023 12:14 pm
Biodesix, Inc. (BDSX) Reports Q4 Loss, Misses Revenue Estimates - Mar 6th, 2023 12:25 pm
Biodesix Announces Fourth Quarter and Fiscal Year End 2022 Results and Highlights - Mar 6th, 2023 11:00 am
Biodesix to Participate at Cowen’s 43rd Annual Healthcare Conference - Feb 28th, 2023 11:00 am
Biodesix to Report Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023 - Feb 21st, 2023 11:00 am
Even after rising 15% this past week, Biodesix (NASDAQ:BDSX) shareholders are still down 39% over the past year - Feb 16th, 2023 11:27 am
Biodesix Announces First Four Private Payer Coverage Policies for the Nodify XL2® Test - Dec 19th, 2022 11:00 am
Biodesix Announces Appointment of Lawrence (Lair) T. Kennedy, Jr. to Board of Directors - Dec 16th, 2022 9:01 pm
Biodesix Ranked Top Proteomics Solutions Company by Life Sciences Review Magazine - Dec 12th, 2022 11:00 am
Biodesix Announces Closing of Upsized Public Offering and Full Exercise of Option to Purchase Additional Shares - Nov 21st, 2022 9:01 pm
Biodesix Announces Pricing of $35.1 Million Upsized Public Offering of Common Stock - Nov 17th, 2022 5:26 am
Biodesix Announces Proposed Public Offering of Common Stock - Nov 16th, 2022 9:05 pm
Biodesix Announces Senior Secured Financing Agreement with Perceptive Advisors for Up to $50 Million - Nov 16th, 2022 9:01 pm
Biodesix Presents New Data from the INSIGHT Study at the 2022 Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting - Nov 10th, 2022 2:00 pm
Biodesix Third Quarter 2022 Earnings: Revenues Beat Expectations, EPS Lags - Nov 9th, 2022 10:33 am
Biodesix, Inc. (BDSX) Reports Q3 Loss, Tops Revenue Estimates - Nov 3rd, 2022 11:15 am
Biodesix Announces Third Quarter 2022 Results and Highlights - Nov 3rd, 2022 10:00 am
Biodesix to Report Third Quarter 2022 Financial Results on November 3, 2022 - Oct 20th, 2022 10:00 am
Boulder's Biodesix snags $20M contract, plans move to larger space in Louisville - Oct 17th, 2022 9:05 pm